Parabilis Medicines's mission is to add life to years and years to life for patients through the invention of transformative new medicines and reaching universal druggability. The company is pioneering the discovery, development, and commercialization of Helicon™ peptides, a new drug modality that uniquely combines the broad targeting power of monoclonal antibodies with the cell-penetrating ability of small molecules. Helicon™ peptides hold the promise, not only to drug nearly all human disease drivers, but also to do so with unrivaled speed and scalability.

We are a vibrant and driven group of scientists and science lovers, with a strong entrepreneurial spirit, and deep commitment to our mission. We are looking for outstanding individuals who are inspired to “drug the undruggable”, to invent the future of medicines, and make a difference in patients’ lives.